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Abstract: Recently, scientific and technological interest in the synthesis of novel  
peptide-based hydrogel materials have grown dramatically. Applications of such materials 
mostly concern the biomedical field with examples covering sectors such as drug delivery, 
tissue engineering, and production of scaffolds for cell growth, thanks to their biocompatibility 
and biodegradability. In this work we synthesized Fmoc-Phe3 based hydrogels of different 
chirality by using a biocatalytic approach. Moreover, we investigated the possibility of 
employing a crosslinker during the biosynthetic process and we studied and compared some 
chemico-physical features of both crosslinked and non-crosslinked hydrogels. In particular, 
we investigated the rheological properties of such materials, as well as their swelling ability, 
stability in aqueous medium, and their structure by SEM and AFM analysis. Crosslinked and 
non-crosslinked hydrogels could be formed by this procedure with comparable yields but 
distinct chemico-physical features. We entrapped dexamethasone within nanopolymeric 
particles based on PLGA coated or not with chitosan and we embedded these nanoparticles 
into the hydrogels. Dexamethasone release from such a nanopolymer/hydrogel system was 
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controlled and sustained and dependent on genipin crosslinking degree. The possibility of 
efficiently coupling a drug delivery system to hydrogel materials seem particularly 
promising for tissue engineering applications, where the hydrogel could provide cells the 
necessary support for their growth, while nanoparticles could favor cell growth or 
differentiation by providing them the necessary bioactive molecules. 
Keywords: peptide hydrogel; biosynthesis; drug delivery  
 
1. Introduction 
Tissue engineering and regenerative medicine are part of an emerging multi- and interdisciplinary 
field that applies the principles of engineering and life sciences towards the development of biological 
substitutes [1,2]. Such research fields have the potential to revolutionize the way health and quality of 
life are improved for millions of people worldwide by restoring, maintaining, or enhancing tissue and 
organ function. Different elements are believed to be crucial for successful tissue regeneration: stem 
cells, growth factor, and scaffold. Cells provide the machinery for new tissue growth and differentiation, 
whereas growth factors and other molecules modulate the cellular activity and provide stimuli for cells 
to differentiate and support tissue neogenesis. 
A three-dimensional template structure for cell growth is provided by scaffolds able to support and 
facilitate the processes that are critical for tissue regeneration [3]. The nanotechnology approach to 
scaffold design and synthesis is an emerging area of research and study [4,5], one of the current biggest 
challenges is to exploit self-assembly processes (the spontaneous organization of matter into specific 
arrangements) to obtain materials and devices with innovative characteristics and functions, especially 
for biomedical and biotechnological use [6,7]. The aim is to achieve pre-defined specific, ordered or 
disordered, structures via the rational design of elementary “building blocks”. In this  
“bottom-up approach”, the effort is made in the direction of a rational design of the elementary 
components of the requested structure. Despite the large emphasis on the importance of the bottom-up 
approach in the production of new materials, up to now research has mostly focused on the synthesis 
and characterization of novel nanoparticles or of new macromolecules with the potential to self-assemble 
and, less frequently, on the study of collective structures (micelles, fibers, sheets, or three-dimensional 
networks, gels) arising from their self-assembly. 
Peptide hydrogels are interesting materials that are currently studied for their potential use in 
biomedical applications [8,9]. Recently, we have reported the lipase-supported synthesis of  
Fmoc-tripeptides, which occur in an aqueous phase through a reverse hydrolysis reaction [10]. These 
materials are biocompatible, as well as biodegradable and they possess a very interesting feature, which 
is their injectability, since the precursors used for their synthesis are liquid at room temperature. The 
possibility to use such biomaterials as drug delivery vehicles induced many scientists to investigate the 
possibility of modulating the crosslinking degree of the macromolecular 3D structures by using different 
crosslinking agents. 
Genipin is a natural compound, found in Gardenia jasminoides fruit extracts. It has traditionally been 
used in herbal medicine and as a food dye [11,12]. Genipin is known to be able to act as a crosslinking 
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agent for proteins and aminoacids, affording stable cross-linked products. In particular peptidic 
hydrogels can exhibit, as a function of their crosslinking degree, different mechanical properties in 
comparison to the non-crosslinked ones. Moreover, such chemical modification may be able to influence 
their in vivo stability. The mechanism of the genipin crosslinking reaction is still not fully understood, 
however it involves the formation of genipin dimers that bind amine groups on adjacent proteins [13,14], 
that give a blue-colored reaction product. Genipin is a particularly interesting cross-linking agent 
because of its low cytotoxicity, especially if compared with traditional crosslinkers such as 
glutaraldehyde and epoxy compounds [15]. Moreover, it has been recently reported that the presence of 
genepin may favor cell adhesion to artificial matrices [16]. For the above reasons, the use of genipin in 
the preparation of new materials for biomedical applications is highly attractive. So far, it has been used 
to crosslink polymeric hydrogel-forming materials such as gelatin and fibrin [16,17] or polypeptide 
hydrogels [18]. 
In this work, we used genipin for the first time as a crosslinker for Fmoc-tripeptide hydrogels of 
different chirality, synthesized by a lipase-supported reaction in aqueous phase that we developed in the 
past [10,19]. We characterized the rheological and chemico-physical properties of the obtained materials 
and we compared them with those of non-crosslinked ones in order to assess if genipin-mediated 
crosslinking could provide attractive features to the hydrogels in view of their use in tissue engineering 
approaches. In fact, such materials may be used as artificial scaffolds for cell growth, an approach that 
may lead to future applications in tissue engineering. With this objective, we loaded the hydrogels with 
a model drug, dexamethasone (DXM), and we studied its release kinetics from the different hydrogel 
materials also by using nanopolymeric vectors based on polylactic-co-glycolic polymers embededded 
with the Desamethsone (DXM) with the aim to modulate drug release. 
2. Results and Discussion 
2.1. Hydrogel Biosynthesis 
Both FmocF and FmocF* were used in lipase-catalyzed reversed hydrolysis reactions using respectively 
FF and F*F* dipeptides, with the formation of a peptide bond between the Fmoc-aminoacid and the 
dipeptide (Figure 1). The reaction products are FmocFFF and FmocF*F*F* tripeptides. The reaction 
conditions for such bioconversions have been optimized in previous works [19] and were employed both 
for non-crosslinked as well as for genipin-crosslinked hydrogels. As far as the crosslinked gels 
preparation is concerned, different genipin concentrations were used, corresponding to values ranging 
from 1/2000 to 1/20 with respect to the amount of Fmoc-aminoacid used. All the bioconversions, with 
and without genipin, afforded self-supporting hydrogels in the employed reaction conditions in about  
20 min, as evidenced by the inversion test. Chemically crosslinked gels were more firm to the touch and 
more easily removable from the glass vials in which they were formed, while gels fabricated without 
genipin were more easily torn during handling. For genipin-crosslinked hydrogels, a blue color, evidence 
of the ongoing crosslinking reaction, appeared within a few hours of hydrogel preparation. The reaction 
yields for all bioconversions were calculated, affording the results shown in Table 1. Such results, 
obtained for non-crosslinked gels and for gels crosslinked with the highest genipin concentration used, 
evidence that the presence of genipin did not affect the tripeptide reaction yield. 
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Figure 1. Reaction scheme of FmocFFF or FmocF*F*F* formation. 
Table 1. Reaction yields of PFL-catalyzed bioconversions. Reaction conditions: 40 μmol of 
Fmoc-aminoacid and dipeptide, 5 mg of PFL (Pseudomonas fluorescence lipase), 100 μL of 
10 mM genipin solution, aqueous phase total volume = 3 mL, pH 7.0, T = 30 °C, reaction 
time 30 min. Values are the means ± s.d. of three independent experiments. 
Material Reaction Yield (%) 
FmocF*F*F* 50 ± 2 
Genipin-crosslinked FmocF*F*F* 53 ± 3 
FmocFFF 27 ± 2 
Genipin-crosslinked FmocFFF 32 ± 2 
Preliminary investigations showed that genipin can react both with the dipeptide, that possesses  
an –NH2 group, as well as with the Fmoc-tripeptide, that possesses three –NH groups, but not with the 
Fmoc-aminoacid. The crosslinking reaction starts while the enzymatic reaction occurs, therefore genipin 
most probably reacts both with the dipeptide as well as with the Fmoc-tripeptide, whose formation 
triggers self-assembly and hydrogel formation [10]. Although the presence of genipin in the reaction 
medium does not influence the reaction yield of tripeptide formation, it could significantly influence the 
self-assembly and three-dimensional organization of the final product. 
2.2. Rheological Measurements 
As previously reported by the authors [20] the storage modulus, G', is remarkably sensitive to the 
chirality of the Fmoc-peptide. As shown in Figure 2A, when the polymer network formation involves 
the D isomer FmocF*F*F*, the value of G' at equilibrium is about twice the value of the storage modulus 
obtained when the L isomer is used. Such a result can be explained on the basis of an increase in the  
Fmoc-peptide reaction yield, as well as on the different structure and size of the fibers obtained by  
using substrates with D-chirality. When genipin is added, the mechanical behavior of the gel is reversed. 
The mechanical spectra of the genipin-treated hydrogels (Figure 2B) show that the L isomer provides a 
firmer hydrogel than the D. 
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Figure 2. Time evolution of storage modulus (G') of FmocFFF and FmocF*F*F* alone (A) 
and with 10 mM genipin (B). T = 30 °C. 
G' values are known to be directly proportional to the cross-linking density. An evaluation of the 
initial rate of the cross-linking reaction can provide information on the difference in the formation of the 
crosslinks in the presence of the two isomers. In the initial part of the kinetics of Fmoc-tripeptides 
without genipin, where a linear trend is expected, the slope of the curve obtained with D is about the 
double of the slope registered in the presence of the L isomer. This finding corroborates the results 
highlighted in the mechanical spectra of Figure 3A. 
The presence of genipin lowers the initial growth rate of G' for both isomers. However, consistently 
with the results of Figure 3B, genipin enhances the G' growth of the L- with respect to the D- isomer. 
This may reflect a different microscopic organization of the reaction products. 
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Figure 3. Mechanical spectra of FmocFFF and FmocF*F*F* in the absence of genipin, (A), 
and with 10 mM genipin, (B). T = 25 °C. Strain = 1%. Measurements were performed after 
overnight equilibration. 
2.3. Swelling Ratio and Weight Loss Ratio Measurements 
Hydrogel materials designed for biomedical applications will come in contact with biological fluids 
in vivo. Studying in vitro the behavior of such materials in the presence of aqueous-based solutions  
that simulate the in vivo environment, such as buffered solutions or Ringer solution, are therefore 
important and may afford valuable information on the in vivo interactions of the hydrogels with the 
surrounding environment. 
Figure 4 shows the swelling ratios of Fmoc-based hydrogels with different chirality, crosslinked with 
different genipin concentrations. As reported previously [20], hydrogels with an L chirality show lower 
swelling abilities than their D counterparts, and this is confirmed also for the genipin-crosslinked 
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materials. Crosslinked hydrogels have lower swelling ratios than non-crosslinked ones (that are around 
100%), with no significant differences among the different genipin concentrations used. This behavior 
may indicate that crosslinked Fmoc-tripeptides preferably interact with the crosslinker or with other 
tripeptide molecules, rather than with water molecules, therefore their swelling is lower, with values 
between 27% and 50%. 
 
Figure 4. Swelling ratios of peptidic hydrogels with different chirality and genipin concentration 
in the presence of Ringer solution. 
The effect of a Ringer solution on the stability of the hydrogels, evaluated through their weight loss 
ratios, was also studied after an incubation of 30 days, a period of time that can be considered long for 
such materials. Results are reported in Figure 5. Non-crosslinked hydrogels have a weight loss ratio of 
about 18%, with no significant differences between the two enantiomers. Cross-linked hydrogels show 
higher weight loss ratios, between 24% and 38%. There is no clear relation between the amount of 
crosslinker used and the weight loss ratio of the crosslinked material. Comparing these results with those 
obtained with different hydrogel materials, such as agar–kappa-carrageenan blend cross-linked with 
genipin [21], that show weight loss ratios of 15%–40% in approximately two days, we can affirm that 
all our materials are quite stable. 
 
Figure 5. Weight loss ratios in the presence of a Ringer solution of peptidic hydrogels with 
different chirality and genipin concentration. 
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2.4. DXM in Vitro Release Studies 
Peptide hydrogels are considered promising materials for biomedical applications, i.e., tissue 
engineering and tissue regeneration applications. Currently, three elements are considered to be crucial 
for successful tissue regeneration: stem cells, scaffold and growth factors or other chemicals used for  
in vitro cell differentiation, such as DXM. Therefore, the possibility of employing a hydrogel scaffold 
as a drug delivery system is a key to the application of such materials in regenerative medicine. With the 
aim to evaluate the potential of Fmoc-tripeptide hydrogels in this sense, we studied the release kinetics 
of a model drug into a buffered medium. 
Figure 6 shows DXM release kinetics from the peptidic hydrogel matrices of different chirality, both 
crosslinked with genipin at two different concentrations and non-crosslinked. 
 
Figure 6. DXM release kinetics from hydrogel matrices with different chirality:  
FmocFFF (A) and FmocF*F*F* (B). 
DXM is released at a higher rate from hydrogels with L chirality, both crosslinked or non-crosslinked, 
reaching values between 30% and 40% of the total DXM amount in approximately one week, providing 
a slow and sustained drug release over time. On the other hand, hydrogels with D chirality release 20%–
25% of DXM in the same time frame. This may be due to the different microscopic structure of 
hydrogels, which is closely linked to their chirality [20]. Overall, in accordance with the respective yields 
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of tripeptide formation, D-amino acid based hydrogels are more “dense” materials, that detain entrapped 
drugs more than their L counterparts. The presence of genipin-based crosslinking in the hydrogels did 
not affect significantly the total amount of released DXM, but had an effect on the release kinetics. All 
the tested materials were able to release the drug in a sustained manner and showed no burst effects, but 
rather an almost constant release over time. 
Moreover, we evaluated DXM release kinetics from polymeric NPs entrapped within FmocFFF and 
FmocF*F*F* hydrogels (Figure 7). Such hydrogels were chosen because their mechanical properties 
were the most promising among the materials studied in this work. Also in this case chirality had  
an influence on drug release, which, as observed for the release of free DXM from Fmoc-based hydrogels 
discussed above, reached higher values for hydrogels with L chirality. Moreover, for both gels a higher 
release rate was evidenced for uncoated PLGA NPs in comparison with (CS)-coated NPs. Overall, both 
formulations afforded a significantly slow and sustained DXM release over time, reaching values 
between 8% and 20% of released DXM in approximately seven days. Previous studies on NPs alone 
have already evidenced that DXM is entirely released from such formulations within a couple of  
hours [22], therefore the presence of the hydrogel matrix is responsible for obtaining a controlled drug 
release system. Both the gel and PLGA-based NPs seem to be able to interact with DXM and the synergy 
between such interactions affords its release in a sustained way. In conclusion, the direct encapsulation 
of DXM into the hydrogel seems to provide a more efficient and sustained release over time, making the 
system appealing for drug delivery approaches. On the other hand, the slower DXM release provided by 
the use of NPs, ensuring higher DXM concentrations within the hydrogel matrix, could be interesting in 
tissue engineering applications, i.e., cells grown within the hydrogel. 
 
Figure 7. DXM release kinetics from PLGA and CS-PLGA NPs entrapped within FmocFFF 
and FmocF*F*F* hydrogel matrices. 
2.5. SEM and AFM Measurements 
SEM and AFM were employed for the investigation of the morphology of fibers and hydrogels, also 
in the presence of genipin. In these studies, we chose to focus on D-peptide based hydrogels, on the  
basis of their promising characteristics, also evidenced by our previous works [20]. Figure 8 shows the 
morphology of FmocF*F*F* alone and crosslinked with genipin obtained by SEM and AFM. Such 
investigations revealed that all the peptidic hydrogels self-assemble with similar features, also in the 
Gels 2015, 1 188 
 
 
presence of chemical crosslinking, giving rise to nanofibers with similar structure. However, the 
presence of genipin seems to afford a different three-dimensional arrangement of the fibers, that results 
in an increase of fiber density. Also, in such conditions, the number of interconnections and knots 
between different fibers appears to increase, thus contributing to a more entangled organization of the 
hydrogel scaffold. In all the selected images, the fibers seem to be rather uniform in morphology and 
highly interconnected with knots. AFM analysis of the size of the fibers, both in the presence and in  
the absence of genipin, gives a narrow size distribution, with the same size, measured in the vertical 
direction of AFM images, of approximately 8 nm. Interestingly, in both hydrogels the R-handed twist 
repeats along the fiber length is visible (see, for example, the fibers marked by an arrow in panels B  
and E). The fiber pitch measured for FmocF*F*F* seems to be larger in respect to that of the same 
hydrogel crosslinked with genipin (around 50 nm and 30 nm, respectively, as determined from 
longitudinal profiles shown in corresponding panels H and I). This structural feature has to be further 
investigated in genipin-crosslinked FmocF*F*F* because it is observed with a minor clarity than in the 
non-crosslinked hydrogel, probably due to a variation of the imaging quality during the AFM scan. 
 
Figure 8. Cont. 
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Figure 8. Morphology of FmocF*F*F* (A-B) and FmocF*F*F* crosslinked with 0.25 mM 
genipin (C-D-E) obtained by SEM (A-C) and AFM (B-D-E) microscopy. Panel E shows  
a magnification of the region delimited by a square in panel D. Bars in panel A-C-D 
correspond to 1 μm, in panels B and E to 100 nm. Panels F and G show the height profile  
of the fibers of FmocF*F*F* and FmocF*F*F* crosslinked with genipin, respectively, 
measured along the sections individuated by a continuous line in panels B and E. Arrows  
in panels F and G indicate fibers where twisting is visible, whose longitudinal section is  
reported in panel H and I. 
3. Conclusions 
Fmoc-Phe3 based hydrogels of different chirality prepared by using a biocatalytic approach have been 
chemically crosslinked with genipin. SEM and AFM investigations revealed that the peptidic hydrogels 
crosslinked with genipin are porous with highly entangled fibers. We also studied and compared some 
chemico-physical features of both crosslinked and non-crosslinked hydrogels obtaining biomaterials 
with different elastic modulus G'. Moreover, DXM encapsulation into the hydrogel seems to provide a 
more efficient and sustained release over time, making the system appealing for drug delivery approaches. 
Overall, the results of these studies indicate that FmocF*F*F*–genipin hydrogels may be a useful 
scaffold for a variety of tissue engineering applications. We are currently attempting to discern the 
mechanisms of genipin crosslinking and determine the in vitro and in vivo cell attachment and 
degradation rate of genipin-crosslinked hydrogels. 
4. Experimental Section 
4.1. Materials 
Fluorenylmethyloxycarbonyl-L-phenylalanine (FmocF) (>99%), Fluorenylmethyloxycarbonyl-D-
phenylalanine (FmocF*) (>99%), L-diphenylalanine (FF) (>99%) and D-diphenylalanine (F*F*) (>99%) 
were purchased from Bachem GmbH (Weil am Rhein, Germany). Lipase from Pseudomonas fluorescens 
(PFL) (≥20.000 U/mg), genipin (≥98%) and all other chemicals were purchased from Sigma Aldrich (St. 
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Louis, MO, USA) and used without further purification. All solvents used in HPLC analysis were of 
HPLC grade and used as received. 
4.2. Biosynthesis of Peptide Hydrogels 
F-moc tripeptide hydrogels of different chirality (FmocFFF and FmocF*F*F*) were prepared as 
previously reported [20]. Briefly, 40 μmol of each substrate, an Fmoc-aminoacid and a dipeptide, were 
suspended in a mixture of 1 mL of H2O and 420 μL of 0.5 M NaOH and magnetically stirred until 
obtaining a homogeneous dispersion. Then, 0.1 M HCl was added to reach a final pH value of 7. A fixed 
amount (100 μL) of enzymatic solution (50 mg/mL) was then added to the substrate suspension and the 
mixture was placed in a thermostated bath at 30 °C for 30 min. 
Crosslinked hydrogels were prepared by following a similar procedure, adding to the substrate 
suspension at pH 7, before the enzymatic solution, a fixed amount (100 μL) of genipin solution with the 
selected concentration (0.1, 0.25, 0.5, 1, 5 and 10 mM). 
Tripeptide final reaction yields were calculated indirectly by measuring Fmoc–Phe amino acid 
disappearance in the reaction medium. The reaction products obtained from the biosynthetic process 
were analyzed 24 h after their preparation. Samples were dissolved in a fixed volume of organic solution 
(60% ACN, 40% H2O, 0.1% TFA). 0.5 M NaOH was also added to a final pH value of 8. The solution 
was then centrifuged at 14.000 rpm for 20 min at constant temperature (25 °C). Naphthalene was added 
to the supernatant as the internal standard. HPLC measurements of the final Fmoc–Phe amino acid in 
the reaction mixture were performed by using the following experimental conditions: C-18 silica 
column, eluent: 60% ACN, 40% H2O, 0.1% TFA, flow rate: 0.9 mL/min, λ = 256 nm. 
4.3. Rheological Measurements 
The viscoelastic behaviour of hydrogels was studied by monitoring the storage and loss moduli, G' 
and G", using an AR2000 rheometer (Waters—TA Instruments, Milan, Italy) equipped with a parallel 
plates geometry (diameter 20 mm, gap 1 mm) with a fixed plate equilibrated at 25 °C. The mechanical 
spectra were obtained recording G' and G" in oscillatory mode, from 0.01 to 100 Hz, at constant strain 
of 1% (limit of the linear viscoelastic strain was about 10%). Kinetics of hydrogel formation at 30 °C 
were carried out by monitoring the time dependence of G' at 30 °C, at the constant frequency of 1 Hz. 
4.4. Swelling and Stability Studies 
The swelling ratios of Fmoc hydrogels in PBS (pH 7.4) were measured by adding to each hydrogel 
sample 3 mL of PBS and incubating it overnight at 30 °C. Fully swollen hydrogels were weighed (Ws) 
immediately after the removal of excess water. Then, the hydrogels were freeze-dried and weighed  
again (Wd). The swelling behavior was expressed, according to Equation (1), as the swelling ratio q,  
that is the ratio between the weight of the swollen sample (Ws) and the weight of the freeze-dried 
hydrogel (Wd) 
q = (Ws − Wd)/Wd (1)
Each experiment was performed in triplicate. 
Gels 2015, 1 191 
 
 
Hydrogel in vitro degradation was evaluated by adding to previously synthesized Fmoc hydrogels  
a fixed amount (8.5 mL) of Ringer solution (NaCl 8.6 mg/mL, KCl 0.3 mg/L. CaCl2 0.33 mg/mL) and 
placing the system in a thermostated bath at 37 °C for 30 days. Hydrogels were weighed before the 
addition of the Ringer solution (W0) and after its removal (Wt) and the weight loss ratio (ΔW) was 
calculated as: 
ΔW = (W0 − Wt)/W0 (2)
4.5. DXM in Vitro Release Experiments 
DXM-loaded hydrogels, containing 6 mg of drug, were prepared by adding DXM-loaded PLGA  
or CS-coated PLGA NPs, or the corresponding amount of free DXM, during hydrogel formation.  
DXM-loaded PLGA or CS-coated PLGA NPs were prepared by a patented methodology [23], as 
described in previous works [24]. The mixture containing hydrogel precursors and free or entrapped 
DXM was then incubated at 30 °C for 1 h for gelation. Self-supporting hydrogels, entrapping DXM in 
their network, were formed in such conditions. After their preparation, DXM-loaded hydrogels were 
incubated in 2 mL of PBS (pH 7.4, 0.1 M) at 37 °C using a thermostated bath. At fixed time intervals, 
the supernatant was withdrawn and substituted with an equal amount of fresh PBS. DXM concentration 
in the supernatants collected at different time points were determined by HPLC by using the following 
experimental conditions: C-18 silica column, eluent: 60% ACN, 40% H2O, 0.1% TFA, flow rate:  
0.9 mL/min, λ = 243 nm. 
4.6. SEM and AFM Measurements 
Hydrogel morphology was investigated by SEM and AFM microscopy. SEM images were collected 
by using a Zeiss Auriga 405 microscope at low extracting voltage (1.5–4 kV) and current (7.5 m aperture), 
in order to reduce the significant charging of the substrate and avoid radiation damages and  
artifacts [25], and at a very low working distance (≈1 mm) to improve the quality of the signal received 
by the in-lens detector. Hydrogel samples were cryo-fractured. Internal fragments were collected,  
freeze-dried, and mounted on an aluminum stab using double-sided carbon tape. 
AFM images of the peptidic hydrogels were acquired in air at room temperature using a Dimension 
Icon (Bruker AXS, Billerica, MA, USA) instrument operating in Scan Asyst™ mode, with dedicated 
probes and using an ultra-sharp silicon tip (nominal radius of curvature 2 nm). This imaging mode allows 
the application of lower forces than standard tapping mode. Sample preparation for AFM measurements 
was performed according to the protocol described in a previous paper [20]. Aliquots of 10–20 μL were 
removed from the peptide hydrogel sample at the end of the gelation process and deposited onto a freshly 
cleaved mica surface. To optimize the amount of peptide adsorbed, each aliquot was left on mica for  
5 min and then gently washed with 200 μL of Milli-Q water. The mica surface with the adsorbed peptide 
was then flushed with a stream of nitrogen for drying, and analyzed after 30 min. Images were analyzed 
using the Gwiddion free software and are presented as raw data, except for flattening. No further image 
processing was carried out. 
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